← Return to Nivolumab aka Opdivo

Discussion

Nivolumab aka Opdivo

Lung Cancer | Last Active: Aug 7 1:37am | Replies (7)
Comment receiving replies
@lls8000

Hi @zora0121, Unfortunately, the research doesn't always keep up with our needs. I'm not an expert, I'm a patient with the ALK mutation. Just because it hasn't been researched and documented doesn't mean that it won't be beneficial for your 2a stage. Have you started the chemo? Have you asked your team about the possibility of immunotherapy?

Jump to this post

Replies to "Hi @zora0121, Unfortunately, the research doesn't always keep up with our needs. I'm not an expert,..."
zora0121 | @zora0121 | Jul 31 8:31pm

I'm on a 4 cucke chemo, just had my 2nd treatment. Unfortunately my oncologist is unwilling or unable to talk to me about Kras mutation, he said 40 percent of cancers have this mutation. Not an issue at this time, promised some creating material never provided it. When I tried to ask about immunotherapy he was very dismissive. We won't talk shout that now, only if it's metastatic..
I have requested a new referral, I'm in Canada and our healthcare has deteriorated unbelievably in the past 8 years.
I do not feel my current oncologist and I can have a meaningful discussion about my care. I'm concerned obviously about that...

VIEW AND REPLY